Artiva Biotherapeutics Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Sep '24 Sep 30, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019
Cash & Equivalents	55.88	53.5	102.53	160.92	25.44	1.87
Short-Term Investments	90.75	23.47	-	-	-	-
Cash & Short-Term Investments	146.63	76.97	102.53	160.92	25.44	1.87
Cash Growth	43.01%	-24.93%	-36.29%	532.51%	1259.08%	-
Accounts Receivable	0.57	1.03	0.53	0.47	-	-
Other Receivables	0.83	0.82	-	-	-	-
Receivables	1.4	1.86	0.53	0.47	-	-
Prepaid Expenses	2.53	0.99	1.62	0.9	0.67	0.09
Total Current Assets	150.57	79.82	104.68	162.29	26.11	1.96
Property, Plant & Equipment	21.51	24.64	27.62	4.08	2.39	2.5
Long-Term Deferred Charges	-	-	-	3.17	0.59	-
Other Long-Term Assets	0.56	0.65	0.76	0.39	0.14	0.38
Total Assets	225.6	105.11	133.05	169.93	29.23	4.84
Accounts Payable	1.22	0.61	1.1	1.44	2.15	0.26
Accrued Expenses	8.34	8.02	10.15	10.13	3.16	0.48
Current Portion of Leases	3.73	3.6	3.49	0.43	0.46	0.21
Current Unearned Revenue	-	-	10.89	7.3	-	-
Total Current Liabilities	13.29	12.23	25.63	19.31	5.76	0.94
Long-Term Debt	-	-	-	-	-	5.64
Long-Term Leases	11.24	13.32	15.96	1.31	1.66	1.97
Long-Term Unearned Revenue	-	-	15.64	21.68	-	-
Other Long-Term Liabilities	0.07	25.17	0.12	0.08	5.31	0.25
Total Liabilities	24.6	50.72	57.34	42.37	12.73	8.8
Additional Paid-In Capital	431.24	18.99	11.9	4.95	0.41	0.03
Retained Earnings	-230.59	-181.31	-152.59	-93.8	-21.98	-3.99
Comprehensive Income & Other	0.34	0.31	-	-	-	-
Total Common Equity	201	-162.02	-140.7	-88.86	-21.57	-3.96
Shareholders' Equity	201	54.4	75.72	127.56	16.5	-3.96
Total Liabilities & Equity	225.6	105.11	133.05	169.93	29.23	4.84
Total Debt	14.97	16.91	19.45	1.74	2.12	7.82
Net Cash (Debt)	131.66	60.06	83.08	159.18	23.33	-5.95
Net Cash Growth	58.47%	-27.71%	-47.81%	582.42%	-	-
Net Cash Per Share	24.54	74.81	108.36	232.10	36.94	-9.76
Filing Date Shares Outstanding	24.29	0.81	0.77	0.71	0.73	0.61
Total Common Shares Outstanding	24.29	0.81	0.77	0.71	0.73	0.61
Working Capital	137.27	67.59	79.05	142.98	20.34	1.02
Book Value Per Share	8.28	-200.07	-183.50	-124.96	-29.71	-6.50
Tangible Book Value	201	-162.02	-140.7	-88.86	-21.57	-3.96
Tangible Book Value Per Share	8.28	-200.07	-183.50	-124.96	-29.71	-6.50
Machinery	11.77	11.24	-	2.78	0.53	0.25
Leasehold Improvements	0.41	0.39	-	0.04	0.04	0.05

Source: S&P Capital IQ. Standard template. Financial Sources.